Clinical Trials on Bronchiolite obliterante polmonite organizzativa
Total 169 results
-
University Hospital, Basel, SwitzerlandRecruitingBronchiolitis Obliterans Syndrome (BOS) | Bronchiolitis Obliterans (BO)Switzerland, Saudi Arabia
-
Washington University School of MedicineThe Foundation for Barnes-Jewish Hospital; Mallinckrodt; Centers for Medicare...Active, not recruitingBronchiolitis Obliterans Syndrome (BOS)United States
-
Renovion, Inc.RecruitingPre-Bronchiolitis Obliterans SyndromeUnited States
-
Children's Hospital Medical Center, CincinnatiRecruitingBronchiolitis Obliterans (BO) | Hematopoietic Stem Cell Transplant (HSCT)United States
-
Zambon SpATerminatedStem Cell Transplant Complications | GVHD, Chronic | Bronchiolitis Obliterans Syndrome (BOS)Spain, France, Germany
-
KU LeuvenUniversity Hospital, Gasthuisberg; Fund for Scientific Research, Flanders,...CompletedGraft Rejection | Respiratory Infection | Bronchiolitis Obliterans Syndrome | Lymphocytic BronchiolitisBelgium
-
University of ChicagoCompletedBronchiolitis Obliterans SyndromeUnited States
-
University Hospital RegensburgClinAssess GmbHUnknownSteroid-refractory Bronchiolitis ObliteransGermany
-
Hopital FochCompletedBronchiolitis Obliterans SyndromeFrance
-
Zambon SpAEnrolling by invitationBronchiolitis Obliterans | Bronchiolitis Obliterans Syndrome | Obliterative BronchiolitisFrance, United States, Spain, Israel, Belgium, Denmark, Germany, United Kingdom, Austria
-
Rigshospitalet, DenmarkCompletedDisorder Related to Lung Transplantation | CLAD, Bronchiolitis ObliteransUnited Kingdom, Belgium, Denmark, Germany, Netherlands, Norway, Sweden
-
Guy's and St Thomas' NHS Foundation TrustADIR AssociationCompletedChronic Lung Allograft Dysfunction | Bronchiolitis Obliterans Syndrome | Transplantation, Heart-LungUnited Kingdom
-
Ann & Robert H Lurie Children's Hospital of ChicagoUnknownBronchiolitis Obliterans SyndromeUnited States
-
Incyte CorporationActive, not recruitingChronic Graft Versus Host Disease | Myelofibrosis | Postlung Transplant (Bronchiolitis Obliterans)United States, Spain, Italy, Germany, Belgium, Austria, Israel, Canada, Greece
-
Universitat Internacional de CatalunyaConsejo Superior de DeportesRecruitingBronchiolitis ObliteransSpain
-
M.D. Anderson Cancer CenterActive, not recruitingBronchiolitis ObliteransUnited States
-
University Hospital, Strasbourg, FranceCompleted
-
Kadmon, a Sanofi CompanyCompletedGraft vs Host DiseaseUnited States
-
Incyte CorporationTerminatedBronchiolitis Obliterans SyndromeUnited States, Belgium, Canada
-
M.D. Anderson Cancer CenterNational Institute of Allergy and Infectious Diseases (NIAID)RecruitingEvaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans SyndromeBronchiolitis ObliteransUnited States
-
Children's Hospital Medical Center, CincinnatiRecruiting
-
Children's Hospital Medical Center, CincinnatiCompletedBronchiolitis Obliterans SyndromeUnited States
-
Hannover Medical SchoolUnknownLung Transplantation | Bronchiolitis Obliterans SyndromeGermany
-
The Hospital for Sick ChildrenRecruitingBronchiolitis Obliterans SyndromeCanada
-
SanofiRecruitingChronic Graft Versus Host DiseaseAustralia, Argentina, Belgium, Spain, Sweden, Czechia, Turkey, United Kingdom, United States, Germany, Italy, Canada, Israel, Denmark, Brazil, Netherlands
-
Incyte CorporationRecruiting
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)RecruitingChronic Graft Versus Host DiseaseUnited States, Canada
-
Pharmacyclics LLC.Janssen Research & Development, LLCActive, not recruitingChronic Graft Versus Host DiseaseUnited States, Spain, Korea, Republic of, Australia, Austria, Canada, France, Germany, Israel, Italy, Netherlands, Russian Federation, United Kingdom
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruitingChronic Graft Versus Host DiseaseChina
-
Assistance Publique - Hôpitaux de ParisRecruitingLung-transplant RecipientsFrance
-
Massachusetts General HospitalIncyte CorporationActive, not recruiting
-
University Hospital, BordeauxRecruitingChronic Graft Versus Host DiseaseFrance
-
Stefanie Sarantopoulos, MD, PhD.National Institutes of Health (NIH); Incyte Corporation; Rigel PharmaceuticalsNot yet recruitingChronic Graft Versus Host DiseaseUnited States
-
Abbisko Therapeutics Co, LtdRecruiting
-
Institut National de la Santé Et de la Recherche...RecruitingBronchiolitis ObliteransFrance
-
Kadmon, a Sanofi CompanyRecruitingChronic Graft Versus Host DiseaseUnited States
-
National Cancer Institute (NCI)Recruiting
-
National Institute of Dental and Craniofacial Research...RecruitingGraft Versus Host DiseaseUnited States
-
Beth Israel Deaconess Medical CenterBristol-Myers Squibb; Dana-Farber Cancer InstituteCompletedChronic Graft Versus Host DiseaseUnited States
-
Southwest Hospital, ChinaXinqiao Hospital of ChongqingRecruitingMesenchymal Stem CellsChina
-
Fred Hutchinson Cancer CenterNational Heart, Lung, and Blood Institute (NHLBI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Bronchiolitis Obliterans SyndromeUnited States
-
Assistance Publique - Hôpitaux de ParisGlaxoSmithKlineTerminatedBronchiolitis Obliterans | Respiratory Disease | Stem Cell Transplant ComplicationsFrance
-
Vanderbilt University Medical Center4DMedicalCompleted
-
Incyte CorporationNot yet recruiting
-
Syndax PharmaceuticalsActive, not recruitingChronic Graft-versus-host-diseaseKorea, Republic of, United States, Spain, Taiwan, France, Singapore, Belgium, Germany, Italy, Canada, Israel, Australia, United Kingdom, Greece, Poland, Portugal
-
Incyte CorporationAvailableChronic Graft Vs. Host Disease
-
Dana-Farber Cancer InstitutePrometheus LaboratoriesActive, not recruitingChronic Graft-versus-host-diseaseUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Prometheus LaboratoriesActive, not recruitingChronic Graft-versus-host DiseaseUnited States
-
Incyte CorporationTerminatedChronic Graft-versus-host DiseaseUnited States, Spain, France, Canada, Israel, United Kingdom, Germany, Italy, Denmark, Sweden, Finland, Belgium, Poland, Greece, Austria, Switzerland
-
Kadmon, a Sanofi CompanyActive, not recruitingChronic Graft-versus-host-diseaseUnited States